A Study of Patients Receiving High-Dose Rate Brachytherapy
NCT00924027 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2025-09-05
Summary
Background:
* One standard way of giving radiation is to combine external beam treatments with internal brachytherapy treatments, which involve short-range radiation therapy that gives a high dose of radiation directly to a cancer or to the area where cancer cells were removed.
* Brachytherapy is done by placing hollow implant device(s) into the area to be treated and then moving a radiation source into each. The type of device depends on the type of cancer and the site to be treated. These devices can range from hollow applicators and needles to balloon-like equipment.
Objectives:
* To evaluate the quality of the brachytherapy procedure at the National Institutes of Health Radiation Oncology Branch.
Eligibility:
* Patients with cancer who could potentially benefit from high-dose brachytherapy as part of their treatment.
Design:
* In conjunction with their existing treatment, patients will be treated with high-dose brachytherapy as determined appropriate for their particular type of cancer and cancer history.
* Each treatment will take place in the Radiation Oncology Clinic.
* If the patient does not have implant devices, the clinic staff will insert them and check their placement through a computed tomography (CT) scan.
* The calculations to determine the appropriate brachytherapy dose will take a few hours; the brachytherapy treatment itself will take between 10 and 30 minutes.
* The number of brachytherapy treatments will vary according to the individual needs and requirements of each type of cancer and each patient.
* Patients will return to the Radiation Oncology Clinic for follow-up visits at 1, 3, 6, 9, and 12 months after the completion of radiation therapy. Follow-up evaluations will include a medical history and physical examination, assessment of any side effects of radiation therapy, and a repeat of any imaging (i.e., CT, magnetic resonance imaging (MRI), X-ray) that was done at baseline to evaluate the tumor response.
Conditions
- Cervical Cancer
- Endometrial Cancer
- Esophageal Cancer
- Prostate Cancer
- Biliary Cancer
Interventions
- RADIATION
-
High Dose Radiation (HDR) Brachytherapy
Brachytherapy, the placement of a radioactive source close to a tumor, is a well-established part of the treatment of many malignancies, both for palliative and definitive applications. High dose brachytherapy is useful in many malignancies in order to deliver a high dose of radiation therapy to tumor in a conformal fashion with a rapid dose fall-off with the objective of sparing normal surrounding tissue.
- DIAGNOSTIC_TEST
-
MRI
When deemed necessary.
- DIAGNOSTIC_TEST
-
CT
Obtained based on the sites of target, as clinical situation dictates and at each follow-up to determine local control.
- DIAGNOSTIC_TEST
-
PET Scan
When deemed necessary.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Deborah E Citrin, M.D. · National Cancer Institute (NCI)
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-14
- Primary Completion
- 2024-05-28
- Completion
- 2025-07-24
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma
NCT03575611 ·Status: SUSPENDED ·Phase: PHASE2
-
A Phase 1 Study of [225Ac]-FPI-1434 Injection
NCT03746431 ·Status: TERMINATED ·Phase: PHASE1
-
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
NCT06909201 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Using MRI To Assess Bladder Motion During Radiotherapy
NCT03409029 ·Status: UNKNOWN ·Phase: NA
-
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
NCT03114462 ·Status: RECRUITING ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT03164460 ·Status: SUSPENDED ·Phase: PHASE2
-
Hemiablative Focal Brachytherapy Pilot Study
NCT02643511 ·Status: UNKNOWN ·Phase: PHASE2
-
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
NCT05994300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
NCT04870840 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
NCT03224000 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
NCT00003045 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
NCT01367301 ·Status: TERMINATED ·Phase: NA
-
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
NCT04484909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
NCT02091050 ·Status: COMPLETED ·Phase: PHASE2
-
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake
NCT03872778 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
NCT02899221 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
NCT05706129 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors
NCT02784652 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction
NCT00009789 ·Status: COMPLETED ·Phase: PHASE1
-
High Dose Radiotherapy for Palliation (Hi-D)
NCT07291895 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT06768125 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors
NCT00006456 ·Status: COMPLETED ·Phase: PHASE2
-
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
NCT06487403 ·Status: RECRUITING ·Phase: NA
-
MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery
NCT06815289 ·Status: RECRUITING ·Phase: NA